Non-alcoholic Fatty Liver Disease
Conditions
Interventions
Control Group:Polyene Phosphatidylcholine Capsules (Sanofi, Approval No. H20059010, 228mg/capsule), 2 capsules bid
Observation group:The control group received polyene phosphatidylcholine capsules combined with a modified version of Yin Chen Hao Tang and Si Ni San: Artemisia capillaris 30g, Gardenia jasminoides 10
Sponsors
Hubei Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 2.1 Meet the diagnostic criteria in section 1.2; 2.2 No other medications taken within 3 months; 2.3 No allergy to study medications; 2.4 Complete clinical data with good compliance; 2.5 Informed consent obtained.
Exclusion criteria
Exclusion criteria: 3.1 Viral/autoimmune liver diseases; 3.2 Severe cardiac/cerebral/renal/hematologic/immune disorders or malignancies; 3.3 Pregnant/lactating women; 3.4 Alcoholic liver disease/viral hepatitis/cirrhosis/liver cancer; 3.5 Psychiatric disorders/severe metabolic diseases/trauma/infections; 3.6 Non-compliant patients/families; 3.7 Unable to understand/sign informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body Mass Index (BMI);Body Weight (kg);Waist Circumference (cm);blood lipids;Liver Function;Oxidative Stress Markers;Liver Fibrosis Markers;Adverse Reaction;VAS Score for Main Symptoms;TCM Syndrome Score; | — |
Countries
China
Contacts
Public ContactCai Jingling
Hubei Provincial Hospital of Traditional Chinese Medicine
Outcome results
None listed